Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 879

1.

T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.

Barbara G, Alloui A, Nargeot J, Lory P, Eschalier A, Bourinet E, Chemin J.

J Neurosci. 2009 Oct 21;29(42):13106-14. doi: 10.1523/JNEUROSCI.2919-09.2009.

2.

Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine.

Ross HR, Gilmore AJ, Connor M.

Br J Pharmacol. 2009 Mar;156(5):740-50. doi: 10.1111/j.1476-5381.2008.00072.x. Epub 2009 Feb 16.

3.

The Cav3.2/alpha1H T-type Ca2+ current is a molecular determinant of excitatory effects of GABA in adult sensory neurons.

Aptel H, Hilaire C, Pieraut S, Boukhaddaoui H, Mallié S, Valmier J, Scamps F.

Mol Cell Neurosci. 2007 Oct;36(2):293-303. Epub 2007 Jul 24.

PMID:
17716912
4.

Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation.

Callaghan B, Haythornthwaite A, Berecki G, Clark RJ, Craik DJ, Adams DJ.

J Neurosci. 2008 Oct 22;28(43):10943-51. doi: 10.1523/JNEUROSCI.3594-08.2008.

5.

Calcium channel gamma6 subunits are unique modulators of low voltage-activated (Cav3.1) calcium current.

Hansen JP, Chen RS, Larsen JK, Chu PJ, Janes DM, Weis KE, Best PM.

J Mol Cell Cardiol. 2004 Dec;37(6):1147-58.

PMID:
15572045
6.

The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents.

Drígelová M, Tarabová B, Duburs G, Lacinová L.

Can J Physiol Pharmacol. 2009 Nov;87(11):923-32. doi: 10.1139/y09-086.

PMID:
19935900
7.

Effects of eugenol on T-type Ca2+ channel isoforms.

Seo H, Li HY, Perez-Reyes E, Lee JH.

J Pharmacol Exp Ther. 2013 Nov;347(2):310-7. doi: 10.1124/jpet.113.207936. Epub 2013 Sep 6.

8.

The CaV3.1 T-type Ca2+channel contributes to voltage-dependent calcium currents in rat outer hair cells.

Inagaki A, Ugawa S, Yamamura H, Murakami S, Shimada S.

Brain Res. 2008 Mar 27;1201:68-77. doi: 10.1016/j.brainres.2008.01.058. Epub 2008 Feb 2.

PMID:
18294617
9.

Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells.

Sekiguchi F, Miyamoto Y, Kanaoka D, Ide H, Yoshida S, Ohkubo T, Kawabata A.

Biochem Biophys Res Commun. 2014 Feb 28;445(1):225-9. doi: 10.1016/j.bbrc.2014.01.185. Epub 2014 Feb 6.

PMID:
24508802
10.

In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.

Kraus RL, Li Y, Gregan Y, Gotter AL, Uebele VN, Fox SV, Doran SM, Barrow JC, Yang ZQ, Reger TS, Koblan KS, Renger JJ.

J Pharmacol Exp Ther. 2010 Nov;335(2):409-17. doi: 10.1124/jpet.110.171058. Epub 2010 Aug 3.

12.

Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.

Maeda Y, Aoki Y, Sekiguchi F, Matsunami M, Takahashi T, Nishikawa H, Kawabata A.

Pain. 2009 Mar;142(1-2):127-32. doi: 10.1016/j.pain.2008.12.021. Epub 2009 Jan 23.

PMID:
19167819
13.

Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.

Abbadie C, McManus OB, Sun SY, Bugianesi RM, Dai G, Haedo RJ, Herrington JB, Kaczorowski GJ, Smith MM, Swensen AM, Warren VA, Williams B, Arneric SP, Eduljee C, Snutch TP, Tringham EW, Jochnowitz N, Liang A, Euan MacIntyre D, McGowan E, Mistry S, White VV, Hoyt SB, London C, Lyons KA, Bunting PB, Volksdorf S, Duffy JL.

J Pharmacol Exp Ther. 2010 Aug;334(2):545-55. doi: 10.1124/jpet.110.166363. Epub 2010 May 3.

14.

The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.

Wen XJ, Xu SY, Chen ZX, Yang CX, Liang H, Li H.

Pharmacology. 2010;85(5):295-300. doi: 10.1159/000276981. Epub 2010 May 5.

PMID:
20453553
15.

A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain.

Hildebrand ME, Smith PL, Bladen C, Eduljee C, Xie JY, Chen L, Fee-Maki M, Doering CJ, Mezeyova J, Zhu Y, Belardetti F, Pajouhesh H, Parker D, Arneric SP, Parmar M, Porreca F, Tringham E, Zamponi GW, Snutch TP.

Pain. 2011 Apr;152(4):833-43. doi: 10.1016/j.pain.2010.12.035. Epub 2011 Feb 23.

PMID:
21349638
16.

Selective inhibition of Cav3.3 T-type calcium channels by Galphaq/11-coupled muscarinic acetylcholine receptors.

Hildebrand ME, David LS, Hamid J, Mulatz K, Garcia E, Zamponi GW, Snutch TP.

J Biol Chem. 2007 Jul 20;282(29):21043-55. Epub 2007 May 29.

17.

Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.

Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K, Kusaka H, Matsubara M.

Eur J Pharmacol. 2008 Apr 28;584(2-3):424-34. doi: 10.1016/j.ejphar.2008.02.001. Epub 2008 Feb 12.

PMID:
18331727
19.
20.

Effects of eugenol on Na+ currents in rat dorsal root ganglion neurons.

Cho JS, Kim TH, Lim JM, Song JH.

Brain Res. 2008 Dec 3;1243:53-62. doi: 10.1016/j.brainres.2008.09.030. Epub 2008 Sep 19.

PMID:
18824159

Supplemental Content

Support Center